London: There is more encouraging news on the COVID vaccine front.
The UK is expected to authorize the Oxford-AstraZeneca vaccine by December 28 or 29 while the US Food and Drug Administration (FDA) granted emergency-use authorisation to a second vaccine — Moderna’s mRNA vaccine.
“The Oxford vaccine is expected to be approved within days of Christmas, kickstarting a massive drive to give jabs to millions of people in January,” The Daily Telegraph reported.
UK has already rolled out a massive inoculation programme with the Pfizer-BioNTech vaccine. Once the Oxford-AstraZeneca vaccine AZD1222 gets the regulator’s nod, it will boost chances of necessary approvals in India too. Serum Institute of India — which is testing and manufacturing the Oxford vaccine candidate — hopes that the vaccination drive in India will begin in India in January.
In the US, healthcare workers will be administered Moderna’s vaccine from Monday, a week after Pfizer-BioNTech’s vaccine was rolled out.
The US is the world’s worst-hit country, with over 315,000 succumbing to the deadly coronavirus and almost 2 lakh positive cases being reported daily now.
New Delhi: A private plane crashed in Gramado, a popular mountain resort town in Brazil,…
Keonjhar: Desecration of a Hanuman idol in Barbil area of Odisha's Keonjhar district triggered stiff…
Mumbai: The much-delayed schedule for the 2025 Champions Trophy has been finalised. As per the…
Raipur: Did actor Sunny Leone enroll for a Chhattisgarh government’s beneficiary scheme for economically weaker…
Berhampur: Continuing to target places of worship in different parts of Odisha, burglars struck at…
New York: US President-elect Donald Trump has nominated an Indian American entrepreneur and former aide…
This website uses cookies.